The Food and Drug Administration (FDA) has approved the first generic version of Venofer ® (iron sucrose) Injection.

(HealthDay News) — Many individuals who are not up to date with recommended vaccinations would accept vaccines if offered during an emergency department visit, according to research published in the ...

The ArteraAI Prostate Test is intended to assist clinicians and patients with risk-based decisions in localized prostate cancer.

This is the first randomized trial to investigate metastasis-directed therapy plus continuous androgen deprivation therapy for oligometastatic prostate cancer.

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

(HealthDay News) — Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published ...

Magnetic stimulation plus bladder training and TTNS plus bladder training are both more effective than bladder training alone.

Observational study findings link dialysis dose reduction to worse postoperative patient survival.